ALAN SOFRANKO: Open Payments
NPI 1508995853 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 13 payments from 8 companies in 2025. Trend: 2023 $155 · 2024 $264 · 2025 $313
Food & beverage: $259Education: $55
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $99 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA, INGREZZA, UZEDY, BRIXADI, REXULTI.
Industry payments across PA — which companies pay providers there.
